Results 191 to 200 of about 3,244,508 (257)
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect. [PDF]
Clatot J +4 more
europepmc +1 more source
Digital technologies in care for older adults living alone: a scoping review. [PDF]
Xu W, Yang B, Teerawichitchainan B.
europepmc +1 more source
A Systematic Review on the Role of Postoperative Radiotherapy in Pelvic Ewing Sarcoma. [PDF]
Hong A +16 more
europepmc +1 more source
CDK4/6 inhibitors rechallenge post-progression in HR-positive HER2-negative advanced/metastatic breast cancer patients: a meta-analysis of Kaplan-Meier-reconstructed individual-level data. [PDF]
Veta Darkovski J +5 more
europepmc +1 more source
Systemic sclerosis and primary biliary cholangitis: a systematic review of case-control studies comparing isolated and overlapping disease phenotypes. [PDF]
Nursoy M +6 more
europepmc +1 more source

